Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,096 | 29,374 | 0 | 0 | 0 |
| Marketable Securities | 4,970 | 3,768 | 0 | 0 | 0 |
| Receivables | 1,618 | 1,697 | 0 | 0 | 0 |
| Other current assets | 3,195 | 2,535 | 0 | 0 | 0 |
| TOTAL | $35,204 | $38,286 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 321 | 348 | N/A | N/A | N/A |
| Other Non-Current Assets | 18 | 20 | 0 | 0 | 0 |
| TOTAL | $339 | $368 | $N/A | $N/A | $N/A |
| Total Assets | $35,543 | $38,654 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 509 | 176 | 0 | 0 | 0 |
| Accrued Expenses | 3,311 | 2,347 | 0 | 0 | 0 |
| TOTAL | $3,820 | $2,523 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22 | 27 | 0 | 0 | 0 |
| TOTAL | $22 | $27 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,842 | $2,550 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 536 | N/A | N/A | N/A | N/A |
| Retained earnings | -28,126 | -23,579 | 0 | 0 | 0 |
| Other shareholders' equity | 58,314 | 58,310 | 0 | 0 | 0 |
| TOTAL | $31,701 | $36,104 | $0 | $0 | $0 |
| Total Liabilities And Equity | $35,543 | $38,654 | $0 | $0 | $0 |